drug
sonidegib phosphate
Marketedupdated 5mo agoby Sun Pharmaceutical Industries Ltd
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying sonidegib phosphate
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jul 24, 2029
~2.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (3)
- Mar 30, 2036compositionUS 10266523
- Sep 15, 2029compositionUS 80630433.0y
- Jul 24, 2029compositionUS 81785632.8y
News(1)
- Highlight Therapeutics illuminates positive ph. 2 topline data in high-risk skin cancerHighlight Therapeutics touted positive topline results in patients with localized high-risk head and neck basal cell carcinoma (BCC).fiercebiotech · 4d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that